MedPath

Vall d'Hebron Research Institute

Vall d'Hebron Research Institute logo
🇪🇸Spain
Ownership
Private
Established
1994-01-01
Employees
1K
Market Cap
-
Website
http://www.vhir.org

The Role of IL33/ST2 Axis in ARDS Patients

Completed
Conditions
Acute Respiratory Distress Syndrome
First Posted Date
2015-07-08
Last Posted Date
2019-02-26
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
200
Registration Number
NCT02492204
Locations
🇪🇸

Hospital Universitary Vall d´Hebron, Barcelona, Spain

Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)

Not Applicable
Completed
Conditions
Chronic Hepatitis C
Portal Hypertension
Cirrhosis
First Posted Date
2015-05-08
Last Posted Date
2017-05-11
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
41
Registration Number
NCT02439567
Locations
🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Spain

Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)

Conditions
Diabetic Nephropathy
Diabetic Retinopathy
Endothelial Dysfunction
Microalbuminuria
Interventions
Other: non intervention
First Posted Date
2015-04-07
Last Posted Date
2017-07-25
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
75
Registration Number
NCT02409511
Locations
🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Spain

GENETIC SUSCEPTIBILITY FACTOR AS A PREDICTOR OF TYPE 2 DIABETES REMISSION AND WEIGHT LOSS AFTER BARIATRIC SURGERY

Completed
Conditions
Case-control Study
Interventions
Genetic: Genetic test
First Posted Date
2015-04-01
Last Posted Date
2015-04-01
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
100
Registration Number
NCT02405949
Locations
🇪🇸

Hospital Universitario Vall d´Hebron, Barcelona, Spain

COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial

Phase 3
Completed
Conditions
ST Elevation Acute Myocardial Infarction
Interventions
Other: Remote Ischemic Conditioning (RIC)
Drug: Placebo
First Posted Date
2015-03-31
Last Posted Date
2020-11-03
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
378
Registration Number
NCT02404376
Locations
🇪🇸

Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

🇪🇸

Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain

🇪🇸

Hospital Universitario Valle de Hebron, Barcelona, Spain

and more 3 locations

Placebo-controlled, Randomized Trial of a Simplified Biofeedback Technique for the Treatment of Rumination

Not Applicable
Completed
Conditions
Rumination Disorders
Interventions
Drug: Placebo
Behavioral: Biofeedback
First Posted Date
2015-03-30
Last Posted Date
2019-08-09
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
24
Registration Number
NCT02402946
Locations
🇪🇸

University Hospital Vall d'Hebron, Barcelona, Catalunya, Spain

🇪🇸

Fernando Azpiroz, Barcelona, Spain

Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy

Phase 4
Conditions
Cirrhosis
Hepatic Encephalopathy
Interventions
Drug: Placebo
First Posted Date
2015-03-27
Last Posted Date
2017-12-28
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
128
Registration Number
NCT02401490
Locations
🇪🇸

Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain

🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Spain

🇪🇸

Hospital Clínic de Barcelona, Barcelona, Spain

and more 4 locations

The Use of Liposomated Iron After Bariatric Surgery in Patients That Are Receiving Parentheral Therapy With Iron

Phase 4
Completed
Conditions
Liposomated Iron
Y-de-Roux Gastric By-Pass
Parenteral Iron Therapy
Interventions
Drug: Fisiogen Ferro Forte
First Posted Date
2015-03-18
Last Posted Date
2017-04-12
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
40
Registration Number
NCT02390921
Locations
🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Spain

Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease

Completed
Conditions
Retinal Neurodegeneration
Alzheimer´s Disease
Type 2 Diabetes
First Posted Date
2015-02-10
Last Posted Date
2017-04-12
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
126
Registration Number
NCT02360527
Locations
🇪🇸

Vall d´Hebron Research Institute VHIR, Barcelona, Catalunya, Spain

"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population

Conditions
Type2 Diabetes Mellitus
Microangiopathy
Cerebrovascular Disease
Acute Coronary Syndrome/ Myocardial Infarction
Non Alcoholic Fatty Liver Disease
Coronary Artery Disease
Ictus
First Posted Date
2014-09-25
Last Posted Date
2018-01-23
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
260
Registration Number
NCT02248311
Locations
🇪🇸

Hospital Universitario Valle de Hebron, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath